Sharpless

Karius Inc. Adds Dr. Norman Sharpless, Former National Cancer Institute Head, and Elizabeth O'Farrell, Eli Lilly Veteran, to its Board of Directors

Retrieved on: 
Thursday, August 10, 2023

Sharpless, highly regarded for his contributions to healthcare leadership and patient-centric innovation, served as the Director of the National Cancer Institute (NCI) from 2017 to 2022.

Key Points: 
  • Sharpless, highly regarded for his contributions to healthcare leadership and patient-centric innovation, served as the Director of the National Cancer Institute (NCI) from 2017 to 2022.
  • In 2019, Sharpless served as the U.S. Food and Drug Administration's (FDA) Acting Commissioner for seven months.
  • Former Eli Lilly executive, O'Farrell, joins the Board with more than two decades of global responsibility within a multinational public company.
  • "I'm very excited to have the opportunity to join the Karius Board of Directors at such an exciting time for the company," O'Farrell said.

Clarivate Experts Celebrate 2022 Nobel Success with Seven Laureates Identified via Citation Analysis

Retrieved on: 
Wednesday, October 12, 2022

LONDON, Oct. 12, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today celebrates the seven new Nobel Laureates across the fields of science and economics who were accurately identified as potential Nobel Prize recipients. Each individual was awarded the designation of Citation Laureate™ several years before being named by the Nobel Assembly – four, more than a decade – thanks to expert interpretation of high-quality citation data at Clarivate.

Key Points: 
  • Using this unique approach, Clarivate identifies researchers of Nobel class on its annual Citation Laureates list and forecasts potential Nobel Prize recipients.
  • This year, Clarivate anticipated Nobel Laureates in three fields: Physics, Chemistry and Economics, demonstrating the association between the citation record which reflects influence throughout a research community and peer judgement.
  • Since 2002, there have been 71 Citation Laureates who have gone on to receive a Nobel Prize.
  • The seven Citation Laureates named as Nobel Laureates in 2022 are:
    The 2022 Nobel Prize for Physics, awarded to Alain Aspect, John F. Clauser and Anton Zeilinger, for experiments with entangled photons, establishing the violation of Bell inequalities and pioneering quantum information science.

Clarivate Experts Celebrate 2022 Nobel Success with Seven Laureates Identified via Citation Analysis

Retrieved on: 
Wednesday, October 12, 2022

LONDON, Oct. 12, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today celebrates the seven new Nobel Laureates across the fields of science and economics who were accurately identified as potential Nobel Prize recipients. Each individual was awarded the designation of Citation Laureate™ several years before being named by the Nobel Assembly – four, more than a decade – thanks to expert interpretation of high-quality citation data at Clarivate.

Key Points: 
  • Using this unique approach, Clarivate identifies researchers of Nobel class on its annual Citation Laureates list and forecasts potential Nobel Prize recipients.
  • This year, Clarivate anticipated Nobel Laureates in three fields: Physics, Chemistry and Economics, demonstrating the association between the citation record which reflects influence throughout a research community and peer judgement.
  • Since 2002, there have been 71 Citation Laureates who have gone on to receive a Nobel Prize.
  • The seven Citation Laureates named as Nobel Laureates in 2022 are:
    The 2022 Nobel Prize for Physics, awarded to Alain Aspect, John F. Clauser and Anton Zeilinger, for experiments with entangled photons, establishing the violation of Bell inequalities and pioneering quantum information science.

K. Barry Sharpless, 1959 Alumnus of Friends' Central School, Wins Second Nobel Prize

Retrieved on: 
Wednesday, October 12, 2022

WYNNEWOOD, Pa., Oct. 7, 2022 /PRNewswire/ -- Only five scientists in history have won a Nobel prize twice, and among those five is K. Barry Sharpless, a Class of 1959 alumnus of Friends' Central School in Wynnewood, Pennsylvania.

Key Points: 
  • WYNNEWOOD, Pa., Oct. 7, 2022 /PRNewswire/ -- Only five scientists in history have won a Nobel prize twice, and among those five is K. Barry Sharpless, a Class of 1959 alumnus of Friends' Central School in Wynnewood, Pennsylvania.
  • On October 5, the 2022 Nobel prize in chemistry was awarded to scientists K. Barry Sharpless, Carolyn Bertozzi, at Stanford University, and Morten Meldal, at the University of Copenhagen.
  • The three were recognized for devising a method to "click" molecules together that has been described as working like "molecular Lego."
  • K. Barry Sharpless won his first Nobel prize in chemistry in 2001 for his work on catalyzed oxidation reactions, another type of chemical reaction used to produce drugs.

Global N-Methylmorpholine Market Report 2022: A 50+ Million Market by 2027 - Forecast and Analysis 2016-2027 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 18, 2022

The "Global N-Methylmorpholine Market, By Type, Technology, & By Region - Forecast and Analysis 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global N-Methylmorpholine Market, By Type, Technology, & By Region - Forecast and Analysis 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global n-methylmorpholine market was valued at USD 45.24 Million in 2021, and it is expected to reach a value of USD 50.65 Million by 2027, at a CAGR of more than 1.90% over the forecast period (2022 - 2027).
  • N-Methylmorpholine (NMM) (CAS 109-02-4) is a clear, low-color, water-miscible, liquid amine possessing a penetrating, ammoniacal odor.
  • N-Methylmorpholine N-oxide (more precisely 4-methyl morpholine 4-oxide), also known as NMO or NMMO, is an organic compound.

Laura Dern honored at star-studded Oceana SeaChange Summer Party

Retrieved on: 
Monday, October 25, 2021

The actor, activist, and longtime Oceana board member served as host for the event.

Key Points: 
  • The actor, activist, and longtime Oceana board member served as host for the event.
  • Actor, musician, and Oceana supporter Mary Steenburgen, who is married to Danson, introduced event honoree, Academy Award-winning actress and activist Laura Dern.
  • You could be dealing with many more wells and many more leaky pipelines, Andrew Sharpless, CEO of Oceana, told attendees.
  • Along with Wahler chairing the SeaChange event, Oceana board member Valarie Van Cleave served as Chair Emeriti and Jeff Blasingame as Vice Chair.

Polymers "click" together using green chemistry

Retrieved on: 
Monday, August 16, 2021

In a paper in Nature Chemistry, they describe a new set of modifiable polymers made from SOF4.

Key Points: 
  • In a paper in Nature Chemistry, they describe a new set of modifiable polymers made from SOF4.
  • Zuilhof says, "The goals of the various research groups were different, but we combined all our expertise to achieve our many goals."
  • The great potential of the SOF4 chemistry inspired me to make the gas by myself, even though the procedure seemed dangerous."
  • This new chemistry will allow scientists to generate a vast new library of polymers, each with its own distinct properties and applications in drug discovery and material science.

Dr. Scott A. May joins Asymchem's Board of Scientific Advisors

Retrieved on: 
Wednesday, March 13, 2019

TIANJIN, China, March 13, 2019 /PRNewswire/ --Asymchem, a leading CDMO of Intermediates and API's for the pharmaceutical industry, today announced that Dr. Scott A.

Key Points: 
  • TIANJIN, China, March 13, 2019 /PRNewswire/ --Asymchem, a leading CDMO of Intermediates and API's for the pharmaceutical industry, today announced that Dr. Scott A.
  • May has joined the Asymchem Board of Scientific Advisors (BSA).
  • Dr. May joins Professors Barry Sharpless, Phil Baran, Stephen Buchwald and others currently on the advisory board.
  • May received his Ph.D. in Chemistry from Indiana University at Bloomington in 1998.